Shared on31 Jul 25Fair value Increased 3.90%
Globe Life’s consensus analyst price target increased modestly, reflecting slightly improved valuation sentiment as both the discount rate and future P/E remained virtually unchanged, resulting in a new target of $156.91. What's in the News SEC has concluded its investigation and does not intend to recommend enforcement action against Globe Life.
Shared on30 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on23 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on17 Apr 25Fair value Decreased 2.74%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on09 Apr 25Fair value Increased 1.35%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on02 Apr 25Fair value Increased 2.71%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on26 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on19 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on10 Mar 25Fair value Decreased 4.59%
AnalystConsensusTarget has decreased revenue growth from 5.2% to 4.7%.